Cylite is a pioneering brand dedicated to revolutionizing the future of eye health. Since 2013, the passionate team of Australian researchers and innovators at Cylite has been developing a groundbreaking optical coherence tomography (OCT) technology. Their mission is to assist optometry, ophthalmology, and research specialists in achieving better patient outcomes.

This innovative OCT addresses the challenge of eye movement artifacts, which hindered the accuracy of previous scans, especially in the anterior segment. Leveraging their extensive expertise in optics, the Cylite founding team created a completely different approach to OCT. They devised a technology that could accurately measure the surfaces and layers of the eye, both in the anterior segment and retina.

Cylite's dedication to excellence has led them to present their work at prestigious science conferences, including Photonics West and Laser World of Photonics. With numerous awarded patents, Cylite is poised to redefine the field of OCT in ophthalmology and optometry. Led by a team of experienced leaders, including CEO Kylee Hall and Executive Director Steve Frisken, Cylite is committed to pushing the boundaries of eye health technology.

With their expertise, dedication, and groundbreaking approach, Cylite is driving advancements in the field and improving patient care